V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019875 | 270009432 | 1.58 | 66 | Palliative (P) | 2017-06-02 | 2018-03-06 | Bevacizumab + Oxaliplatin +MdG | N | Y | 270015884 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270019876 | 270009436 | 1.61 | 62.9 | Curative (C) | null | 2017-03-27 | CETUXIMAB + RT | N | N | 270015892 | CETUXIMAB + RT |
| 270019878 | 270009459 | 1.58 | 72 | Palliative (P) | 2017-03-03 | 2017-04-15 | Capecitabine (14 day) + Irinotecan | 02 | Y | 270015948 | CAPECITABINE + IRINOTECAN |
| 270019879 | 270009469 | 1.66 | 127 | Palliative (P) | 2016-06-09 | 2016-06-14 | CISPLATIN + FLUOROURACIL | N | N | 270015983 | CISPLATIN + FLUOROURACIL |
| 270019880 | 270009486 | 1.76 | 69 | Palliative (P) | 2015-02-28 | 2015-02-28 | Fluorouracil + Folinic Acid Weekly | N | N | 270016019 | FLUOROURACIL |
| 270019881 | 270014439 | 1.76 | null | Palliative (P) | 2019-07-01 | 2019-08-03 | Trifluridine + Tipiracil | N | N | 270016033 | TRIFLURIDINE + TIPIRACIL |
| 270019882 | 270019221 | null | null | Neo-adjuvant (N) | 2018-08-23 | 2018-10-09 | Capecitabine (21 day) + Irinotecan | null | null | 270016074 | CAPECITABINE + IRINOTECAN |
| 270019883 | 270009539 | 1.67 | null | Curative (C) | 2019-06-10 | 2020-01-15 | CAPECITABINE + RT | 2 | N | 270016250 | CAPECITABINE + RT |
| 270019884 | 270009556 | 1.47 | 64 | Adjuvant (A) | 2015-08-24 | 2015-09-15 | CAPECITABINE + IRINOTECAN | null | null | 270016297 | CAPECITABINE + IRINOTECAN |
| 270019885 | 270009582 | 1.6 | 78.5 | Palliative (P) | 2019-05-15 | 2019-05-15 | Trifluridine + Tipiracil | N | N | 270016371 | TRIFLURIDINE + TIPIRACIL |
| 270019886 | 270009595 | null | 64.7 | Palliative (P) | 2015-01-20 | 2015-02-19 | Oxaliplatin + Raltitrexed | N | null | 270016405 | PANITUMUMAB |
| 270019887 | 270009608 | -1 | 90 | Palliative (P) | 2018-08-27 | 2018-08-28 | VEPEMB | 2 | N | 270016426 | VINBLASTINE |
| 270019888 | 270014498 | 1.73 | 95.6 | Palliative (P) | 2016-11-20 | 2017-07-26 | BENDAMUSTINE | N | 2 | 270016438 | BENDAMUSTINE |
| 270019889 | 270009614 | 1.62 | 83.8 | Curative (C) | 2018-10-24 | 2018-10-24 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | 270016441 | CETUXIMAB + OXALIPLATIN + MDG |
| 270019890 | 270009628 | 1.68 | null | Adjuvant (A) | 2015-04-25 | 2015-06-10 | IGEV | 2 | N | 270016490 | VEPEMB |
| 270019891 | 270017001 | 0 | null | Adjuvant (A) | null | 2019-02-19 | IVE | N | null | 270016559 | IVE |
| 270019892 | 270019691 | null | 81.7 | Curative (C) | 2018-04-04 | 2018-07-04 | Bevacizumab 5mg/kg | 02 | N | 270016596 | VEPEMB |
| 270019893 | 270009661 | 1.67 | null | Curative (C) | 2016-04-19 | 2016-04-21 | Bevacizumab 5mg/kg | N | N | 270016605 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270019894 | 270014524 | 1.79 | null | Palliative (P) | 2019-03-08 | 2019-03-08 | IVE | 02 | N | 270016607 | IVE |
| 270019895 | 270009670 | 1.74 | 103.1 | Not known (9) | 2017-05-29 | 2018-09-15 | GDP | 2 | N | 270016619 | GDP |
| 270019896 | 270009677 | null | 71.7 | Palliative (P) | 2017-09-22 | 2017-09-22 | Bevacizumab | N | N | 270016635 | CISPLATIN + GEMCITABINE |
| 270019897 | 270009686 | 1.55 | 68.8 | Curative (C) | 2017-02-02 | 2017-02-02 | Vinblastine | N | N | 270016660 | VEPEMB |
| 270019898 | 270009696 | 1.57 | 59 | Curative (C) | 2015-07-25 | 2015-07-25 | Panitumumab | 2 | N | 270016682 | VEPEMB |
| 270019899 | 270017025 | null | 95.6 | Palliative (P) | 2014-05-01 | 2014-05-03 | Carboplatin AUC 6 - 10 | 2 | null | 270016705 | BEVACIZUMAB |
| 270019900 | 270014549 | 1.8 | null | Curative (C) | null | 2015-10-19 | Vinblastine | null | N | 270016708 | PANITUMUMAB |
| 270019901 | 270019246 | 1.67 | 64 | Palliative (P) | 2014-05-19 | 2014-06-04 | Cisplatin+Gemcitabine (Days 1&8&15) | 2 | N | 270016761 | CISPLATIN + GEMCITABINE |
| 270019902 | 270009742 | 1.69 | 60.6 | Curative (C) | 2014-11-17 | 2014-11-18 | Bevacizumab 5mg/kg | N | N | 270016783 | OXALIPLATIN + RALTITREXED |
| 270019903 | 270009755 | 1.8 | null | Curative (C) | 2020-02-27 | 2020-05-06 | AFLIBERCEPT + FU + IRINOTECAN | N | null | 270016828 | CETUXIMAB + OXALIPLATIN + MDG |
| 270019904 | 270014577 | 1.63 | null | Curative (C) | 2015-04-05 | 2015-04-06 | ABVD R | N | N | 270016872 | BEAM + ALEMTUZUMAB |
| 270019905 | 270009783 | 1.71 | 78.4 | Curative (C) | 2016-12-28 | 2017-05-21 | GDP | N | N | 270016922 | GDP |
| 270019906 | 270009786 | 1.55 | 36.8 | Adjuvant (A) | null | 2017-07-01 | NIVOLUMAB | N | N | 270016939 | OXALIPLATIN + RALTITREXED |
| 270019907 | 270009789 | 1.69 | null | Palliative (P) | 2016-04-24 | 2016-07-21 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270016950 | BEVACIZUMAB |
| 270019908 | 270009806 | 1.61 | 52.8 | Curative (C) | 2019-02-23 | 2019-02-27 | Bevacizumab 5mg/kg | 02 | null | 270016989 | PANITUMUMAB |
| 270019909 | 270009821 | 1.67 | 76.9 | Curative (C) | 2014-12-27 | 2015-01-03 | CISPLATIN + GEMCITABINE | 02 | N | 270017016 | AFLIBERCEPT + FU + IRINOTECAN |
| 270019910 | 270009828 | 1.78 | 57.2 | Curative (C) | 2017-06-26 | 2017-06-26 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270017022 | CISPLATIN + GEMCITABINE |
| 270019911 | 270009836 | 1.8 | null | Curative (C) | 2017-05-17 | 2017-05-23 | NIVOLUMAB | N | N | 270017044 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270019912 | 270014606 | 1.69 | 73.3 | Curative (C) | 2016-12-07 | 2016-12-11 | BEAM + Alemtuzumab Allo SCT | 2 | N | 270017056 | CISPLATIN + GEMCITABINE |
| 270019913 | 270009849 | 1.8 | 71 | Curative (C) | 2019-06-10 | 2019-06-10 | GDP | N | N | 270017063 | GDP |
| 270019914 | 270009872 | 1.66 | 99.8 | Curative (C) | 2019-05-18 | 2019-05-22 | GDP | 02 | null | 270017117 | GDP |
| 270019915 | 270009904 | 1.8 | 83.8 | Curative (C) | 2014-08-14 | 2015-03-05 | Cisplatin | 02 | N | 270017233 | NIVOLUMAB |
| 270019916 | 270009920 | 1.8 | 86.3 | Palliative (P) | 2013-12-21 | 2014-01-01 | CISPLATIN + GEMCITABINE | N | N | 270017260 | NIVOLUMAB |
| 270019917 | 270009935 | 1.52 | 56 | Palliative (P) | 2015-10-21 | 2015-12-01 | Irinotecan 14day | 2 | N | 270017287 | IRINOTECAN |
| 270019918 | 270009938 | 1.78 | 85 | Adjuvant (A) | 2016-08-30 | 2016-11-01 | Irinotecan | 02 | N | 270017290 | IRINOTECAN |
| 270019919 | 270009955 | 1.5 | 75.8 | Palliative (P) | 2017-11-14 | 2018-01-01 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 270017306 | CETUXIMAB + OXALIPLATIN + MDG |
| 270019920 | 270009966 | 1.8 | 95.6 | Palliative (P) | 2016-01-27 | 2016-02-11 | BEAM + Alemtuzumab Allo SCT | 2 | Y | 270017328 | GEMCITABINE |
| 270019921 | 270014658 | 0 | 56 | Curative (C) | 2018-04-12 | 2018-04-21 | IGEV | 2 | N | 270017330 | ABVD R |
| 270019922 | 270009992 | 1.56 | 36.8 | Curative (C) | 2017-04-28 | 2017-05-07 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 270017382 | IGEV |
| 270019923 | 270010002 | 1.67 | null | null | null | 2019-09-16 | BEAM + Alemtuzumab Allo SCT | null | Y | 270017410 | BEVACIZUMAB |
| 270019924 | 270010008 | null | 79.2 | Palliative (P) | null | 2017-02-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 270017427 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 270019925 | 270010017 | 1.63 | null | Curative (C) | 2015-08-01 | 2016-04-22 | OXALIPLATIN | null | null | 270017431 | FLUOROURACIL + RT |